You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nontuberculosis mycobacterial infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

Not yet recruiting
  • Mycobacterium Avium Complex Pulmonary Disease
  • (no location specified)
May 15, 2023

Expectorated and Induced Sputum and Pharyngeal Swabs for

Completed
  • Myobacterium Infections, Nontuberculous
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Mycobacterial and Opportunistic Infections in HIV-Negative Thai

    Active, not recruiting
    • Non-Tuberculous Mycobacteria
    • +2 more
      • Taiwan, China
        National Taiwan University
      Aug 18, 2022

      Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) Trial in United States (Molgramostim nebulizer solution, PARI

      Terminated
      Has Results
      • Mycobacterium Infections, Nontuberculous
      • Cystic Fibrosis (CF)
      • Molgramostim nebulizer solution
      • PARI eFlow nebulizer system
      • Denver, Colorado
      • +4 more
      Oct 10, 2021

      Healthy, Latent Tuberculosis Infection (LTBI) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Tuberculin

      Recruiting
      • Healthy
      • Latent Tuberculosis Infection (LTBI)
      • Tuberculin Purified Protein Derivative
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jul 22, 2022

      Transmission and Acquisition of Nontuberculous Mycobacteria

      Recruiting
      • Nontuberculous Mycobacterial Pulmonary Infection
      • +3 more
      • Epidemiologic investigation
      • Denver, Colorado
        National Jewish Health
      Dec 1, 2023

      Prospective Healthcare-Associated Links in Transmission of

      Enrolling by invitation
      • Cystic Fibrosis
      • Nontuberculous Mycobacterial Pulmonary Infection
        • Denver, Colorado
          National Jewish Health
        Jan 6, 2023

        Mycobacterium Abscessus Infection in Chronic Lung Disease and

        Enrolling by invitation
        • Mycobacterium Abscessus Infection
        • +2 more
        • Appropriate treatment
        • Pathum Wan, Bangkok, Thailand
          King Chulalongkorn Memorial Hospital
        Aug 31, 2022

        PK and PD of Antibiotics for Treatment of Mycobacterium

        Not yet recruiting
        • Nontuberculous Mycobacterial Pulmonary Infection
        • Measuring PK and PD indices in patients who receive conventional treatment
        • (no location specified)
        Dec 22, 2022

        Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

        Recruiting
        • Mycobacterium Infections, Nontuberculous
        • +3 more
        • Omadacycline Oral Tablet
        • Placebo
        • Birmingham, Alabama
        • +20 more
        Jan 11, 2023

        Bronchiectasis, Non-Tuberculous Mycobacterial Pneumonia Trial in Calgary

        Recruiting
        • Bronchiectasis
        • Non-Tuberculous Mycobacterial Pneumonia
          • Calgary, Alberta, Canada
            University of Calgary
          Nov 17, 2023

          Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

          Recruiting
          • Nontuberculous Mycobacterial Lung Disease
          • Nontuberculous Mycobacterium Infection
          • Hypertonic saline
          • +3 more
          • New York, New York
          • +2 more
          Jan 27, 2023

          Nontuberculous Mycobacterium Infection Trial in Portland, Charleston (gNO)

          Completed
          Has Results
          • Nontuberculous Mycobacterium Infection
          • Portland, Oregon
          • +1 more
          May 17, 2021

          Cystic Fibrosis Trial in Aurora (Ethambutol, Rifampin, Azithromycin)

          Completed
          Has Results
          • Cystic Fibrosis
          • Aurora, Colorado
            Children's Hospital Colroado
          Jan 20, 2021

          Mycobacterium Infections, Nontuberculous Trial in Australia, United Kingdom (Inhaled molgramostim)

          Completed
          • Mycobacterium Infections, Nontuberculous
          • Inhaled molgramostim
          • Concord, New South Wales, Australia
          • +4 more
          Mar 23, 2021

          Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

          Not yet recruiting
          • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
          • Placebo
          • +2 more
          • (no location specified)
          Aug 9, 2022

          Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

          Recruiting
          • Non-Tuberculous Mycobacterial Pneumonia
          • +4 more
          • LungFit
          • Greenslopes, Queensland, Australia
            Gallipoli Medical Research Foundation
          Dec 24, 2020

          Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

          Active, not recruiting
          • Mycobacterium Infections, Nontuberculous
          • Birmingham, Alabama
          • +110 more
          Jan 23, 2023

          Performance Evaluation of the VIDAS TB-IGRA Assay.

          Completed
          • Active Tuberculosis
          • +2 more
          • Blood draw and IGRA test
          • Palo Alto, California
          • +23 more
          Jul 14, 2021

          Study of Mycobacterial Infections

          Recruiting
          • Mycobacterium Infections
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 21, 2023

          Tuberculosis, Skin Tests Trial in Saint Petersburg (Mycobacterial recombinant allergens 0.1 µg, Mycobacterial recombinant

          Completed
          • Tuberculosis
          • Skin Tests
          • Mycobacterial recombinant allergens 0.1 μg
          • +2 more
          • Saint Petersburg, Russian Federation
            Limited Liability Company "Scientific Research Center Eco-Safety
          May 31, 2022

          Non-Tuberculous Mycobacterial (NTM) Infections Trial in Canada, United States (Lamprene®/Clofazimine)

          Available
          • Non-Tuberculous Mycobacterial (NTM) Infections
          • (no location specified)
          Dec 14, 2022

          Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Bacterial Infections Trial in Worldwide (Individualised treatment

          Recruiting
          • Tuberculosis, Pulmonary
          • +3 more
          • Individualised treatment duration based on RNA transcriptomic model
          • Borstel, Schleswig-Holstein, Germany
          • +4 more
          Apr 7, 2021

          Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

          Completed
          Has Results
          • Mycobacterium Infections, Nontuberculous
          • LAI (Liposomal Amikacin for Inhalation) 590 mg
          • (no location specified)
          Apr 22, 2020

          Drug Exposure and Minimum Inhibitory Concentration in Treatment

          Not yet recruiting
          • Mycobacterium Avium Complex
          • +3 more
          • Drug exposure
          • Shanghai, China
            Shanghai Pulmonary Hospital
          Apr 10, 2023